Last Updated:
Name Designation Appointment Date Status
Pallavi Kirtikumar Lakdawala

Appointed as Director since January 1999

 Director 01-Jan-1999 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Snoval Pharmaceuticals Pvt Ltd.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Rakesh Mahendra Lakdawala

Appointed as Director since January 1999

 Director 01-Jan-1999 Current
Kirtikumar Manilal Lakdawala

Appointed as Director since July 1995

 Director 18-Jul-1995 Current
Jignesh Mahendra Lakdawala

Appointed as Director since January 1999

 Director 01-Jan-1999 Current

People Timeline

Explore the timeline of key personnel in Snoval Pharmaceuticals Pvt Ltd's leadership journey.

Contact Details
  • Address Plot No 77/4Lakdi Bunder Darukhana, Mumbai Maharashtra, 400010, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 400010
  • Country India
  • Website -
Frequently Asked Questions
You can contact Snoval Pharmaceuticals Pvt Ltd through their registered address at Plot No 77/4Lakdi Bunder Darukhana, Mumbai Maharashtra, 400010, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Snoval Pharmaceuticals Pvt Ltd are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • PALLAVI KIRTIKUMAR LAKDAWALA
  • RAKESH MAHENDRA LAKDAWALA
  • KIRTIKUMAR MANILAL LAKDAWALA
  • JIGNESH MAHENDRA LAKDAWALA
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available